{"transactions":[{"id":4637921,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-10-08T20:30:25.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":23564,"price":0.7444,"value":17541.0416,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":49047,"source":{"system":"sec-edgar","filing":"0001193125-26-417970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846984/000119312526417970/ownership.xml","form_type":"4"}},{"id":4637889,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T20:30:24.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":22669,"price":0.7444,"value":16874.8036,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":70311,"source":{"system":"sec-edgar","filing":"0001193125-26-417971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1846045/000119312526417971/ownership.xml","form_type":"4"}},{"id":4637890,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T20:30:22.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":21829,"price":0.7444,"value":16249.5076,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":80438,"source":{"system":"sec-edgar","filing":"0001193125-26-417969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827847/000119312526417969/ownership.xml","form_type":"4"}},{"id":4637845,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T20:30:09.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":20990,"price":0.7444,"value":15624.956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":44749,"source":{"system":"sec-edgar","filing":"0001193125-26-417974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1979732/000119312526417974/ownership.xml","form_type":"4"}},{"id":691172,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-08-11T20:15:03.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":4363,"price":2.01,"value":8769.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":25483,"source":{"system":"sec-edgar","filing":"0001193125-26-344682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526344682/ownership.xml","form_type":"4"}},{"id":703101,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-27T20:15:29.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":8138,"price":1.92,"value":15624.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":23759,"source":{"system":"sec-edgar","filing":"0001193125-26-318114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318114/ownership.xml","form_type":"4"}},{"id":703100,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T20:15:14.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":4568,"price":1.92,"value":8770.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":21120,"source":{"system":"sec-edgar","filing":"0001193125-26-318105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318105/ownership.xml","form_type":"4"}},{"id":703099,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-27T20:15:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":8463,"price":1.92,"value":16248.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":58609,"source":{"system":"sec-edgar","filing":"0001193125-26-318103","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318103/ownership.xml","form_type":"4"}},{"id":703098,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-27T20:15:04.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":8789,"price":1.92,"value":16874.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":47642,"source":{"system":"sec-edgar","filing":"0001193125-26-318100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318100/ownership.xml","form_type":"4"}},{"id":718918,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:33:32.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3880,"price":2.26,"value":8768.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":16552,"source":{"system":"sec-edgar","filing":"0001193125-26-295004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526295004/ownership.xml","form_type":"4"}},{"id":734704,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-17T20:47:42.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":7761,"price":2.26,"value":17539.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":12672,"source":{"system":"sec-edgar","filing":"0001193125-26-274305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526274305/ownership.xml","form_type":"4"}},{"id":762444,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T20:33:30.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":3700,"price":2.37,"value":8769.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of net salary."}],"balance_after":4911,"source":{"system":"sec-edgar","filing":"0001193125-26-241999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526241999/ownership.xml","form_type":"4"}},{"id":795989,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:30:59.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":6515,"price":2.59,"value":16873.85,"ownership":{"direct":true},"balance_after":38853,"source":{"system":"sec-edgar","filing":"0001193125-26-201557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526201557/ownership.xml","form_type":"4"}},{"id":795990,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:18:01.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":6274,"price":2.59,"value":16249.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":50146,"source":{"system":"sec-edgar","filing":"0001193125-26-201489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526201489/ownership.xml","form_type":"4"}},{"id":795988,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:15:27.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":6032,"price":2.59,"value":15622.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":15621,"source":{"system":"sec-edgar","filing":"0001193125-26-201474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526201474/ownership.xml","form_type":"4"}},{"id":938660,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T21:15:04.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":5406,"price":2.89,"value":15623.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":9589,"source":{"system":"sec-edgar","filing":"0001193125-26-014117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526014117/ownership.xml","form_type":"4"}},{"id":938659,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T21:15:03.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":5622,"price":2.89,"value":16247.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":43872,"source":{"system":"sec-edgar","filing":"0001193125-26-014116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526014116/ownership.xml","form_type":"4"}},{"id":938658,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T21:15:02.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":5839,"price":2.89,"value":16874.71,"ownership":{"direct":true},"balance_after":32338,"source":{"system":"sec-edgar","filing":"0001193125-26-014115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526014115/ownership.xml","form_type":"4"}},{"id":987518,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-27T02:32:20.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":5340,"price":3.16,"value":16874.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":26499,"source":{"system":"sec-edgar","filing":"0001193125-25-301033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525301033/ownership.xml","form_type":"4"}},{"id":987517,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-27T02:26:18.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":5142,"price":3.16,"value":16248.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":38250,"source":{"system":"sec-edgar","filing":"0001193125-25-301026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525301026/ownership.xml","form_type":"4"}},{"id":987516,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-27T02:26:01.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":4183,"price":3.16,"value":13218.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":4183,"source":{"system":"sec-edgar","filing":"0001193125-25-301025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525301025/ownership.xml","form_type":"4"}},{"id":1060603,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-20T23:54:48.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":4000,"derivative":{"exercise_price":2.32,"expiration_date":"2035-08-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-25-110531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025110531/ownership.xml","form_type":"4"}},{"id":1060602,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2025-08-20T23:54:48.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":10775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10775,"source":{"system":"sec-edgar","filing":"0000950170-25-110531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025110531/ownership.xml","form_type":"4"}},{"id":1060601,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-20T23:53:57.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":13676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully vested as of August 18, 2025."}],"balance_after":13676,"derivative":{"exercise_price":2.32,"expiration_date":"2035-08-17","underlying":"Common Stock","underlying_shares":13676},"source":{"system":"sec-edgar","filing":"0000950170-25-110530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025110530/ownership.xml","form_type":"4"}},{"id":1085821,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T21:35:05.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-twelfth of the Option vests each month on the monthly anniversary of July 15, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon. Vesting shall accelerate in full upon Optionholder's death or Disability or a Change of Control."}],"balance_after":3200,"derivative":{"exercise_price":3.4,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0000950170-25-096674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025096674/ownership.xml","form_type":"4"}},{"id":1085820,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T21:35:05.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":3.4,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-096674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025096674/ownership.xml","form_type":"4"}},{"id":1091430,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-07T23:11:39.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon."}],"balance_after":6400,"derivative":{"exercise_price":5,"expiration_date":"2035-07-03","underlying":"Common Stock","underlying_shares":6400},"source":{"system":"sec-edgar","filing":"0000950170-25-094387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094387/ownership.xml","form_type":"4"}},{"id":1091429,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-07T23:11:39.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":4050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 33,133 shares of common stock (29,083 previously owned shares, plus the instant grant of 4,034 RSUs)."}],"balance_after":33133,"source":{"system":"sec-edgar","filing":"0000950170-25-094387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094387/ownership.xml","form_type":"4"}},{"id":1091428,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-07T23:11:11.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-twelfth of the Option vests each month on the monthly anniversary of July 3, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon."}],"balance_after":6400,"derivative":{"exercise_price":5,"expiration_date":"2035-07-03","underlying":"Common Stock","underlying_shares":6400},"source":{"system":"sec-edgar","filing":"0000950170-25-094386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094386/ownership.xml","form_type":"4"}},{"id":1091427,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-07T23:11:11.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (RSUs) which immediately vested upon grant. After the reported acquisition of the RSUs, the reporting person owned in aggregate 21,159 shares of common stock (17,759 previously owned shares, plus the instant grant of 3,400 RSUs)."}],"balance_after":21159,"source":{"system":"sec-edgar","filing":"0000950170-25-094386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094386/ownership.xml","form_type":"4"}},{"id":1091426,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-07T23:08:25.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this grant will vest and become exercisable immediately upon grant and the remaining balance shall vest in substantially equal quarterly installments over a three year period commencing on the Start Date with the first vesting date being October 2, 2025, subject to holder's continuous employment through each vesting date. This option grant shall be subject to the terms and conditions of the Company's 2020 Equity Incentive Plan and a Stock Option Agreement."}],"balance_after":130000,"derivative":{"exercise_price":5.02,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000950170-25-094383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025094383/ownership.xml","form_type":"4"}},{"id":1101250,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2025-06-27T01:22:46.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":4.49,"value":1122.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock is perpetual and therefore has no expiration date."}],"balance_after":250,"derivative":{"exercise_price":4.49,"exercise_date":"2025-06-24","underlying":"Common Stock","underlying_shares":55679.29},"source":{"system":"sec-edgar","filing":"0000950170-25-090589","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090589/ownership.xml","form_type":"4"}},{"id":1101249,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":4.49,"value":2694.0,"ownership":{"direct":false,"nature":"By Watermill Asset Management Corp"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":600,"derivative":{"exercise_price":4.49,"exercise_date":"2025-06-24","underlying":"Common Stock","underlying_shares":133630.29},"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1101248,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.76,"value":1380.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":500,"derivative":{"exercise_price":2.76,"exercise_date":"2025-04-11","underlying":"Common Stock","underlying_shares":181159},"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1101247,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-27T01:19:44.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":20804,"price":2.92,"value":60747.68,"ownership":{"direct":true},"balance_after":29083,"source":{"system":"sec-edgar","filing":"0000950170-25-090587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025090587/ownership.xml","form_type":"4"}},{"id":1172041,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2025-04-16T00:42:09.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.76,"value":1380.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The preferred stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. (\"WaterMill\"). The Reporting Person serves as the principal of WaterMill."}],"balance_after":500,"derivative":{"exercise_price":2.76,"exercise_date":"2025-04-11","underlying":"Common Stock","underlying_shares":181159},"source":{"system":"sec-edgar","filing":"0000950170-25-054436","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054436/ownership.xml","form_type":"4"}},{"id":1172040,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T00:42:09.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":20804,"price":2.92,"value":60747.68,"ownership":{"direct":true},"balance_after":29083,"source":{"system":"sec-edgar","filing":"0000950170-25-054436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054436/ownership.xml","form_type":"4"}},{"id":1172038,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-16T00:33:33.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":10904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully vested as of April 13, 2025."}],"balance_after":10904,"derivative":{"exercise_price":2.92,"expiration_date":"2035-04-12","underlying":"Common Stock","underlying_shares":10904},"source":{"system":"sec-edgar","filing":"0000950170-25-054432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054432/ownership.xml","form_type":"4"}},{"id":1172039,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T00:26:04.000Z","date":"2025-04-13","kind":"grant","planned":false,"acquired":true,"shares":17465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which immediately vested upon grant."}],"balance_after":43359,"source":{"system":"sec-edgar","filing":"0000950170-25-054429","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025054429/ownership.xml","form_type":"4"}},{"id":1186884,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":81385,"kind":"person","name":"Hogue Dale Curtis Jr.","position":1,"cik":"0002006649","reported_name":"Hogue Dale Curtis Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-01T20:21:00.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixth of the shares underlying the option vest in equal monthly installments measured from March 29, 2025, with the first vesting occurring on April 29, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3000,"derivative":{"exercise_price":1.46,"expiration_date":"2035-03-28","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-25-048554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025048554/ownership.xml","form_type":"4"}},{"id":1186883,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Legal & Administration"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-01T20:05:14.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 29, 2025, with the first vesting occurring on June 29, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":1000,"derivative":{"exercise_price":1.46,"expiration_date":"2035-03-28","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-048492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025048492/ownership.xml","form_type":"4"}},{"id":1186882,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-01T20:05:12.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 29, 2025, with the first vesting occurring on June 29, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3000,"derivative":{"exercise_price":1.46,"expiration_date":"2035-03-28","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-25-048491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025048491/ownership.xml","form_type":"4"}},{"id":1315906,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:34:46.000Z","date":"2024-12-31","kind":"sale","planned":false,"acquired":false,"shares":818,"price":2,"value":1636.0,"ownership":{"direct":true},"balance_after":25894,"source":{"system":"sec-edgar","filing":"0000950170-25-001257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025001257/ownership.xml","form_type":"4"}},{"id":1315905,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:34:46.000Z","date":"2024-12-31","kind":"sale","planned":false,"acquired":false,"shares":2182,"price":2.01,"value":4385.82,"ownership":{"direct":true},"balance_after":26712,"source":{"system":"sec-edgar","filing":"0000950170-25-001257","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025001257/ownership.xml","form_type":"4"}},{"id":1431672,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-16T20:35:36.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 14, 2024, with the first vesting occurring on November 14, 2024 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":1500,"derivative":{"exercise_price":2.42,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000950170-24-098103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024098103/ownership.xml","form_type":"4"}},{"id":1431671,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Legal & Administration"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-16T20:05:02.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 14, 2024, with the first vesting occurring on November 14, 2024 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":1500,"derivative":{"exercise_price":2.42,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000950170-24-098045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024098045/ownership.xml","form_type":"4"}},{"id":1485397,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":4524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested as of June 6, 2024."}],"balance_after":4524,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":4524},"source":{"system":"sec-edgar","filing":"0000950170-24-071401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071401/ownership.xml","form_type":"4"}},{"id":1485396,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":19200,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":19200},"source":{"system":"sec-edgar","filing":"0000950170-24-071401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071401/ownership.xml","form_type":"4"}},{"id":1485395,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:12.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":12800,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000950170-24-071400","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071400/ownership.xml","form_type":"4"}},{"id":1485394,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:08.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":12800,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000950170-24-071399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071399/ownership.xml","form_type":"4"}},{"id":1485393,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-10T21:00:05.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon."}],"balance_after":12800,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0000950170-24-071396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024071396/ownership.xml","form_type":"4"}},{"id":1673424,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":81385,"kind":"person","name":"Hogue Dale Curtis Jr.","position":1,"cik":"0002006649","reported_name":"Hogue Dale Curtis Jr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-23T22:47:51.000Z","date":"2024-01-20","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In twelve equal monthly installments measured from January 20, 2024, with the first vesting occurring on February 20, 2024, subject to the Reporting Person's continued service through each such date."}],"balance_after":600000,"derivative":{"exercise_price":0.12,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000950170-24-006700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024006700/ownership.xml","form_type":"4"}},{"id":1693732,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":81385,"kind":"person","name":"Hogue Dale Curtis Jr.","position":1,"cik":"0002006649","reported_name":"Hogue Dale Curtis Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-03T22:30:50.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In five equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date."}],"balance_after":41667,"derivative":{"exercise_price":0.071,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0000950170-24-001195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024001195/ownership.xml","form_type":"4"}},{"id":1693731,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":81385,"kind":"person","name":"Hogue Dale Curtis Jr.","position":1,"cik":"0002006649","reported_name":"Hogue Dale Curtis Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-03T22:30:50.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date."}],"balance_after":150000,"derivative":{"exercise_price":0.071,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-001195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024001195/ownership.xml","form_type":"4"}},{"id":1789698,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-05T21:34:33.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":68014,"price":0.1403,"value":9542.3642,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of shares of Common Stock pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of shares of restricted stock previously granted to the Reporting Person. This sale was effected pursuant to a plan adopted on November 17, 2022 in accordance with Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.14 to $0.1424, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":798236,"source":{"system":"sec-edgar","filing":"0000950170-23-046504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017023046504/ownership.xml","form_type":"4"}},{"id":1862809,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:27:39.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014923/doc4.xml","form_type":"4"}},{"id":1862808,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:24:37.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014920/doc4.xml","form_type":"4"}},{"id":1862807,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":29279,"kind":"person","name":"Thistle Mary","position":1,"cik":"0001317917","reported_name":"Thistle Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-08T21:23:17.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014918/doc4.xml","form_type":"4"}},{"id":1862805,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option\n(right to buy)","published_at":"2023-06-08T21:22:59.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014916/doc4.xml","form_type":"4"}},{"id":1862806,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-08T21:17:59.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014913/doc4.xml","form_type":"4"}},{"id":1862804,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-08T21:10:09.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.48,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-014910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323014910/doc4.xml","form_type":"4"}},{"id":1917456,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T21:00:09.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In equal installments on April 30, 2023 and May 30, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":16667,"derivative":{"exercise_price":0.66,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000899243-23-011453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323011453/doc4.xml","form_type":"4"}},{"id":1917455,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":90115,"kind":"person","name":"Hofmeister Robert","position":1,"cik":"0001760102","reported_name":"Hofmeister Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-19T21:00:09.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from March 30, 2023, with the first vesting occuring on April 30, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":150000,"derivative":{"exercise_price":0.66,"expiration_date":"2033-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-23-011453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323011453/doc4.xml","form_type":"4"}},{"id":1947915,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115441,"kind":"person","name":"Srivastava Abhishek K","position":1,"cik":"0001941863","reported_name":"Srivastava Abhishek K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:20.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on on June 15, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-009002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323009002/doc4.xml","form_type":"4"}},{"id":1947914,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115440,"kind":"person","name":"Wong Michael","position":1,"cik":"0001895407","reported_name":"Wong Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:18.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-009001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323009001/doc4.xml","form_type":"4"}},{"id":1947912,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:15.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":1800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":1800000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":1800000},"source":{"system":"sec-edgar","filing":"0000899243-23-009000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323009000/doc4.xml","form_type":"4"}},{"id":1947913,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115439,"kind":"person","name":"Deniger Drew","position":1,"cik":"0001921961","reported_name":"Deniger Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:12.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-008999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323008999/doc4.xml","form_type":"4"}},{"id":1947909,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:09.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-23-008998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323008998/doc4.xml","form_type":"4"}},{"id":2100310,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:05:19.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":750000,"price":0.65,"value":487500.0,"ownership":{"direct":false,"nature":"By WaterMill Asset Management Corp."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in a registered underwritten offering on November 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp."}],"balance_after":5000000,"source":{"system":"sec-edgar","filing":"0000899243-22-037275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322037275/doc4.xml","form_type":"4"}},{"id":2100305,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:05:15.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":1250000,"price":0.65,"value":812500.0,"ownership":{"direct":false,"nature":"By Brushwood LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased in a registered underwritten offering on November 29, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares are directly held by Brushwood LLC. The Reporting Person is the Manager of Brushwood LLC."}],"balance_after":1250000,"source":{"system":"sec-edgar","filing":"0000899243-22-037274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322037274/doc4.xml","form_type":"4"}},{"id":2156289,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115439,"kind":"person","name":"Deniger Drew","position":1,"cik":"0001921961","reported_name":"Deniger Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research and Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-19T20:30:41.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date."}],"balance_after":305000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0000899243-22-031464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322031464/doc4.xml","form_type":"4"}},{"id":2156288,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115441,"kind":"person","name":"Srivastava Abhishek K","position":1,"cik":"0001941863","reported_name":"Srivastava Abhishek K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-19T20:30:33.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date."}],"balance_after":25000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-031462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322031462/doc4.xml","form_type":"4"}},{"id":2156287,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115440,"kind":"person","name":"Wong Michael","position":1,"cik":"0001895407","reported_name":"Wong Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-19T20:30:21.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-031460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322031460/doc4.xml","form_type":"4"}},{"id":2156337,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Legal"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-19T20:30:09.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date."}],"balance_after":185000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0000899243-22-031459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322031459/doc4.xml","form_type":"4"}},{"id":2169195,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-01T20:30:33.000Z","date":"2022-08-30","kind":"tax_withholding","acquired":false,"shares":18750,"price":2.41,"value":45187.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person."}],"balance_after":866250,"source":{"system":"sec-edgar","filing":"0000899243-22-030186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322030186/doc4.xml","form_type":"4"}},{"id":2184612,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115441,"kind":"person","name":"Srivastava Abhishek K","position":1,"cik":"0001941863","reported_name":"Srivastava Abhishek K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-08-16T21:00:41.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares underlying the options vest on August 3, 2023, and with respect to the remainder, in twelve successive equal quarterly installments measured from August 3, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":250000,"derivative":{"exercise_price":1.65,"expiration_date":"2032-08-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-22-028813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322028813/doc4.xml","form_type":"4"}},{"id":2222288,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":29279,"kind":"person","name":"Thistle Mary","position":1,"cik":"0001317917","reported_name":"Thistle Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:35:41.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-024011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024011/doc4.xml","form_type":"4"}},{"id":2222287,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":29279,"kind":"person","name":"Thistle Mary","position":1,"cik":"0001317917","reported_name":"Thistle Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:35:41.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0000899243-22-024011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024011/doc4.xml","form_type":"4"}},{"id":2222286,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:35:24.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-024006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024006/doc4.xml","form_type":"4"}},{"id":2222285,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:35:24.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188333,"source":{"system":"sec-edgar","filing":"0000899243-22-024006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024006/doc4.xml","form_type":"4"}},{"id":2222284,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:35:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-024005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024005/doc4.xml","form_type":"4"}},{"id":2222283,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:35:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 946,970 shares of common stock underlying units of the Issuer  (the \"Units\"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer."}],"balance_after":1241870,"source":{"system":"sec-edgar","filing":"0000899243-22-024005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322024005/doc4.xml","form_type":"4"}},{"id":2222282,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":29279,"kind":"person","name":"Thistle Mary","position":1,"cik":"0001317917","reported_name":"Thistle Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:32:28.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023997/doc4.xml","form_type":"4"}},{"id":2222281,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":29279,"kind":"person","name":"Thistle Mary","position":1,"cik":"0001317917","reported_name":"Thistle Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:32:28.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0000899243-22-023997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023997/doc4.xml","form_type":"4"}},{"id":2222280,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:53.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023988/doc4.xml","form_type":"4"}},{"id":2222279,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":42283,"kind":"person","name":"Huang James","position":1,"cik":"0001573160","reported_name":"Huang James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:53.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188333,"source":{"system":"sec-edgar","filing":"0000899243-22-023988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023988/doc4.xml","form_type":"4"}},{"id":2222278,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023987/doc4.xml","form_type":"4"}},{"id":2222277,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28607,"kind":"person","name":"Postma Robert W","position":1,"cik":"0001827847","reported_name":"Postma Robert W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 946,970 shares of common stock underlying units of the Issuer  (the \"Units\"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer."}],"balance_after":1241870,"source":{"system":"sec-edgar","filing":"0000899243-22-023987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023987/doc4.xml","form_type":"4"}},{"id":2222276,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:34.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023985/doc4.xml","form_type":"4"}},{"id":2222275,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28606,"kind":"person","name":"Vieser Jaime","position":1,"cik":"0001846045","reported_name":"Vieser Jaime","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:34.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":745321,"source":{"system":"sec-edgar","filing":"0000899243-22-023985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023985/doc4.xml","form_type":"4"}},{"id":2222274,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":39731,"kind":"person","name":"Bowden Christopher","position":1,"cik":"0001608601","reported_name":"Bowden Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:31:03.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023978/doc4.xml","form_type":"4"}},{"id":2222273,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":39731,"kind":"person","name":"Bowden Christopher","position":1,"cik":"0001608601","reported_name":"Bowden Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:31:03.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44167,"source":{"system":"sec-edgar","filing":"0000899243-22-023978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023978/doc4.xml","form_type":"4"}},{"id":2222272,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-24T20:30:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments beginning on July 13, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.82,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-023977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023977/doc4.xml","form_type":"4"}},{"id":2222271,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24727,"kind":"person","name":"Weis Holger","position":1,"cik":"0001846984","reported_name":"Weis Holger","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:30:48.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 30,000 shares held in a joint account by the Reporting Person and his spouse."}],"balance_after":160167,"source":{"system":"sec-edgar","filing":"0000899243-22-023977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322023977/doc4.xml","form_type":"4"}},{"id":2311585,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-01T20:30:50.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date."}],"balance_after":2000000,"derivative":{"exercise_price":0.66,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0000899243-22-013119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322013119/doc4.xml","form_type":"4"}},{"id":2311586,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-01T20:30:29.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date."}],"balance_after":350000,"derivative":{"exercise_price":0.66,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000899243-22-013117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322013117/doc4.xml","form_type":"4"}},{"id":2458775,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":128544,"kind":"person","name":"De Groot Eleanor","position":1,"cik":"0001780420","reported_name":"De Groot Eleanor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Operations"}}],"security":"Common Stock","published_at":"2021-12-27T17:20:38.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":20132,"price":1.27,"value":25567.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":237106,"source":{"system":"sec-edgar","filing":"0000899243-21-049739","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924321049739/doc4.xml","form_type":"4"}},{"id":2476130,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":49979,"kind":"person","name":"Lackey Melinda","position":1,"cik":"0001898184","reported_name":"Lackey Melinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Legal"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-13T11:06:48.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares underlying the options vest on November 29, 2022, and with respect to the remainder, in twelve succesive equal quarterly installments measured from November 29, 2022, subject to the Reporting Person's continued service through each such date."}],"balance_after":370000,"derivative":{"exercise_price":1.22,"expiration_date":"2031-12-09","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0000899243-21-047850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924321047850/doc4.xml","form_type":"4"}},{"id":2508223,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-17T21:53:45.000Z","date":"2021-11-17","kind":"purchase","acquired":true,"shares":9116,"price":1.4,"value":12762.4,"ownership":{"direct":true},"balance_after":885000,"source":{"system":"sec-edgar","filing":"0001209191-21-065138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121065138/doc4.xml","form_type":"4"}},{"id":2508222,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":110006,"kind":"person","name":"Boyle Kevin S. Sr.","position":1,"cik":"0001880600","reported_name":"Boyle Kevin S. Sr.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-17T21:53:45.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":884,"price":1.4,"value":1237.6,"ownership":{"direct":true},"balance_after":875884,"source":{"system":"sec-edgar","filing":"0001209191-21-065138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121065138/doc4.xml","form_type":"4"}}],"next_cursor":"2021-11-17T21:53:45.000000Z,2508222"}